...thought to indicate the extent of fibrogenesis in the liver. The biomarker was identified by Nordic Bioscience A/S...

...Pharmaceuticals Inc. (NASDAQ:LXRX) Amylin receptor; calcitonin receptor Other hormone signaling pathway Unknown DACRA-089 (KBP-089) Peptide Nordic Bioscience A/S...

...The KeyBioscience AG subsidiary of Nordic Bioscience A/S (Herlev, Denmark) granted Eli Lilly and Co. (NYSE:LLY) worldwide rights...
...calcitonin receptors. Lilly declined to disclose additional details, and Nordic Bioscience did not respond to inquiries. Nordic Bioscience A/S...
...Herlev, Denmark Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Alicia Parker Eli Lilly and Co. Nordic Bioscience A/S Amylin...

...Bristol-Myers Squibb and Nordic Bioscience partnered to develop translational biomarkers and diagnostics to detect non-alcoholic steatohepatitis (NASH...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Nordic Bioscience A/S , Herlev, Denmark Business: Diagnostic Julian Zhu Bristol-Myers Squibb Co. Nordic Bioscience A/S...

...2 intra-articular injections of SB-061. Last year, Symic and Nordic partnered to develop Symic's SB-061. Nordic Bioscience A/S...
...rating scale (NRS) of pain Status: Completed Phase I/IIa enrollment Milestone: Phase I/IIa data (1H17) Alex Himes SB-061 Nordic Bioscience A/S Symic...

...SB-061 to treat mild to moderate osteoarthritis of the knee. The product is partnered with Nordic Bioscience A/S...
...NYSE:MDT), Dublin, Ireland NantKwest Inc. (NASDAQ:NK), Cardiff-by-the-Sea, Calif. New WuXi Life Science Ltd., Shanghai, China Nordic Bioscience A/S...

...Symic and Nordic Bioscience began the double-blind, placebo-controlled, Estonian Phase I/II MODIFY-OA trial to evaluate intra-articular injections...
...of SB061 in about 90 patients. In 2015, Symic and Nordic partnered to develop SB061. Nordic Bioscience A/S...

...with expertise in the target disease indications. Symic has a business partnership with the CRO Nordic Bioscience A/S...
...See Table: Biocentury Product Profile) Companies and Institutions Mentioned Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Nordic Bioscience A/S...

...Argenta Discovery 2009 Ltd. partnered with Gruenenthal and Nordic Bioscience to develop preclinical and clinical assays to...
...therapies. Argenta will provide preclinical models, primary cell-based assays, in vivo pharmacology and fibrosis research. Nordic Bioscience...
...disease subsegments, and Gruenenthal will provide expertise on drug discovery and development and coordinate activities. Nordic Bioscience...

...2012 by Alyssa Panitch, John Paderi and Kate Stuart University collaborators: Purdue University Corporate partners: Nordic Bioscience A/S...